Moisand Fitzgerald Tamayo’s Teva Pharmaceuticals TEVA Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.29K	Hold	38	–	–	﹤0.01%	507
2026 Q1	$1.15K	Hold	38	–	–	﹤0.01%	486
2025 Q4	$1.19K	Hold	38	–	–	﹤0.01%	484
2025 Q3	$768	Hold	38	–	–	﹤0.01%	545
2025 Q2	$637	Hold	38	–	–	﹤0.01%	552
2025 Q1	$585	Hold	38	–	–	﹤0.01%	556
2024 Q4	$838	Hold	38	–	–	﹤0.01%	561
2024 Q3	$685	Hold	38	–	–	﹤0.01%	580
2024 Q2	$618	Buy	+38	New	+$585	﹤0.01%	552
2019 Q4	–	Sell	-46	Closed	–	–	289
2019 Q3	$0	Hold	46	–	–	﹤0.01%	287
2019 Q2	$0	Hold	46	–	–	﹤0.01%	286
2019 Q1	$1K	Hold	46	–	–	﹤0.01%	272
2018 Q4	$1K	Hold	46	–	–	﹤0.01%	270
2018 Q3	$1K	Hold	46	–	–	﹤0.01%	294
2018 Q2	$1K	Hold	46	–	–	﹤0.01%	277
2018 Q1	$1K	Hold	46	–	–	﹤0.01%	315
2017 Q4	$1K	Hold	46	–	–	﹤0.01%	276
2017 Q3	$1K	Buy	+46	New	+$1.03K	﹤0.01%	307
2016 Q2	–	Sell	-35	Closed	-$2K	–	182
2016 Q1	$2K	Hold	35	–	–	﹤0.01%	205
2015 Q4	$2K	Buy	+35	New	+$2.16K	﹤0.01%	198

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Moisand Fitzgerald Tamayo's TEVA Position: Q2 2026 in Review

Moisand Fitzgerald Tamayo held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 38 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #507.

Moisand Fitzgerald Tamayo first reported a position in TEVA in Q4 2015 and has held it in 20 quarters since. The position peaked at $2K in Q1 2016. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Moisand Fitzgerald Tamayo held 38 shares of Teva Pharmaceuticals worth $1.29K as of Q2 2026.
Moisand Fitzgerald Tamayo left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Moisand Fitzgerald Tamayo's portfolio in Q2 2026, its #507 holding.
Moisand Fitzgerald Tamayo first reported a position in Teva Pharmaceuticals in Q4 2015 and has held it in 20 quarters since.
Moisand Fitzgerald Tamayo's Teva Pharmaceuticals position peaked at $2K in Q1 2016.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q2 2026, filed 13 Jul 2026.